Does Rallies show Form 4 insider transactions for SNWV?

Yes. Rallies tracks SNWV insider trading and Form 4 activity, including executive purchases, executive sales, transaction dates, shares, and prices when available.

Is SNWV research on Rallies investment advice?

No. Rallies provides research, data, and educational context for SNWV. It does not provide personalized investment advice.

SNWV (SANUWAVE Health, Inc. Common Stock) Stock Analysis - Insider Trades

SANUWAVE Health, Inc. Common Stock (SNWV) is a publicly traded Healthcare sector company. As of May 21, 2026, SNWV trades at $16.75 with a market cap of $144.98M and a P/E ratio of 12.18. SNWV moved +0.78% today. Year to date, SNWV is -42.62%; over the trailing twelve months it is -44.33%. Its 52-week range spans $5.63 to $46.59. Analyst consensus is buy with an average price target of $51.00. Rallies surfaces SNWV's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.

Who is trading SNWV stock inside the company?

Recent SNWV insider activity includes Opaleye Management Inc. sold 10.08K, Opaleye Management Inc. sold 500, Opaleye Management Inc. sold 24.00K, Opaleye Management Inc. sold 1.00K, and Opaleye Management Inc. sold 23.36K. Rallies tracks insider transaction dates, shares, prices, and estimated values.

SNWV Key Metrics

Key financial metrics for SNWV
Metric	Value
Price	$16.75
Market Cap	$144.98M
P/E Ratio	12.18
EPS	$1.38
Dividend Yield	0.00%
52-Week High	$46.59
52-Week Low	$5.63
Volume	0
Avg Volume	0
Revenue (TTM)	$44.05M
Net Income	$11.81M
Gross Margin	77.11%

Recent SNWV Insider Trades

Opaleye Management Inc. sold 10.08K (~$162.41K) on May 1, 2026.
Opaleye Management Inc. sold 500 (~$8.06K) on May 1, 2026.
Opaleye Management Inc. sold 24.00K (~$387.62K) on Apr 30, 2026.
Opaleye Management Inc. sold 1.00K (~$16.15K) on Apr 30, 2026.
Opaleye Management Inc. sold 23.36K (~$402.90K) on Apr 29, 2026.

Latest SNWV News

SANUWAVE Health Posts Record Q1 2026 Revenue Despite Market Headwinds — May 14, 2026
Sanuwave Health Logs Record Q1 Revenue and Increased Consumables Utilization — May 13, 2026
Sanuwave Q1 Revenue Hits $9.6M; Operating Loss of $1.1M — May 12, 2026
Sanuwave Projects Q1 Revenue of $9.6–$9.7M, Up 3–4% Year-Over-Year — Apr 16, 2026

SNWV Analyst Consensus

2 analysts cover SNWV: 0 strong buy, 2 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is buy. Average price target: $51.00.

Common questions about SNWV

Who is trading SNWV stock inside the company?: Recent SNWV insider activity includes Opaleye Management Inc. sold 10.08K, Opaleye Management Inc. sold 500, Opaleye Management Inc. sold 24.00K, Opaleye Management Inc. sold 1.00K, and Opaleye Management Inc. sold 23.36K. Rallies tracks insider transaction dates, shares, prices, and estimated values.
Does Rallies show Form 4 insider transactions for SNWV?: Yes. Rallies tracks SNWV insider trading and Form 4 activity, including executive purchases, executive sales, transaction dates, shares, and prices when available.
Is SNWV research on Rallies investment advice?: No. Rallies provides research, data, and educational context for SNWV. It does not provide personalized investment advice.